Trial Profile

Effect of Neuromuscular Blockade Reversal With Sugammadex on Oxygenation, Pain and Arousal States in the Post Anesthesia Care Unit

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 08 Feb 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Sugammadex (Primary) ; Neostigmine
Indications Neuromuscular blockade
Focus Therapeutic Use
Acronyms Neuropa

Most Recent Events

14 Aug 2016 Status changed from recruiting to completed.
07 Dec 2015 Planned primary completion date changed from 1 Nov 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov.
31 Aug 2015 Planned primary completion date changed from 1 Sep 2015 to 1 Nov 2015, as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com